A. Sakamoto, N. Kasai, H. Sugano, Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52, 1849–1855 (1983)

Article  CAS  PubMed  Google Scholar 

C. Hedinger, Histologic Typing of Thyroid Tumours. International Histological Classification of Turnouts, vol. II (World Health Organization, Geneva, 1974)

J.M. Beaugih, C.L. Brown, I. Doniach, J.E. Richardson, Primary malignant tumours of the thyroid: the relationship between histological classification and clinical behaviour. Br. J. Surg. 63, 173–18I (1976)

Article  Google Scholar 

A.D. McKenzie, The natural history of thyroid cancer: a report of 102 cases analysed 10 to 15 years after diagnosis. Arch. Surg. 102, 274–277 (1971)

D.P. Byar, S.B. Green, P. Dor et al. A prognostic index for thyroid carcinoma: a study of the EORTC Thyroid Cancer Cooperative Group. Eur. J. Cancer 15, 1033–1041 (1979)

T. Langhans, Uber die epithelialen Formen der malignen Struma. Virchows Arch. 189, 69–188 (1907)

Article  Google Scholar 

T. Ibrahimpasic, R. Ghossein, J.P. Shah, I. Ganly, Poorly differentiated carcinoma of the thyroid gland: current status and future prospects. Thyroid 29(3), 311–321 (2019). https://doi.org/10.1089/thy.2018.0509

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.L. Carcangiu, G. Zampi, J. Rosai, Poorly differentiated (‘insular’) thyroid carcinoma. A reinterpretation of Langhans’ ‘wuchernde Struma’. Am. J. Surg. Pathol. 8, 655–668 (1984)

Article  CAS  PubMed  Google Scholar 

M. Volante, P. Collini, Y.E. Nikiforov, A. Sakamoto, K. Kakudo, R. Katoh, R.V. Lloyd, V.A. LiVolsi, M. Papotti, M. Sobrinho-Simoes, G. Bussolati, J. Rosai, Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am. J. Surg. Pathol. 31(8), 1256–1264 (2007). https://doi.org/10.1097/PAS.0b013e3180309e6a

Article  PubMed  Google Scholar 

D. Hiltzik, D.L. Carlson, R.M. Tuttle, S. Chuai, N. Ishill, A. Shaha, J.P. Shah, B. Singh, R.A. Ghossein, Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 106(6), 1286–1295 (2006). https://doi.org/10.1002/cncr.21739

Article  PubMed  Google Scholar 

K.A. Pathak, A. Mazurat, P. Lambert, T. Klonisch, R.W. Nason, Prognostic nomograms to predict oncological outcome of thyroid cancers. J. Clin. Endocrinol. Metab. 98(12), 4768–4775 (2013). https://doi.org/10.1210/jc.2013-2318

Article  CAS  PubMed  Google Scholar 

Y. Ito, M. Hirokawa, M. Fukushima, H. Inoue, T. Yabuta, T. Uruno, M. Kihara, T. Higashiyama, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, A. Miyauchi, Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan. World J. Surg. 32(7), 1535–1543 (2008). https://doi.org/10.1007/s00268-007-9406-7

Article  PubMed  Google Scholar 

C. Saglietti, A.M. Onenerk, W.C. Faquin, G.P. Sykiotis, S. Ziadi, M. Bongiovanni, FNA diagnosis of poorly differentiated thyroid carcinoma. A review of the recent literature. Cytopathology 28(6), 467–474 (2017). https://doi.org/10.1111/cyt.12497

Article  CAS  PubMed  Google Scholar 

M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021)

Article  PubMed  PubMed Central  Google Scholar 

J.J. Barendregt, S.A. Doi, Y.Y. Lee, R.E. Norman, T. Vos, Meta-analysis of prevalence. J. Epidemiol. Community Health 67, 974–978 (2013)

Article  PubMed  Google Scholar 

D. Wang, Z.Y. Mou, J.X. Zhai, H.X. Zong, X.D. Zhao, Application of Stata software to test heterogeneity in meta-analysis method. Zhonghua Liu Xing Bing Xue Za Zhi 29, 726–729 (2008)

CAS  PubMed  Google Scholar 

M.S. Dettmer, A. Schmitt, P. Komminoth, A. Perren, Poorly differentiated thyroid carcinoma: an underdiagnosed entity. Pathologe 41(Suppl 1), 1–8 (2020). https://doi.org/10.1007/s00292-019-0600-9

Article  CAS  PubMed  Google Scholar 

S. Purkait, S. Agarwal, S.R. Mathur, D. Jain, V.K. Iyer, Fine needle aspiration cytology features of poorly differentiated thyroid carcinoma. Cytopathology 27(3), 176–184 (2016). https://doi.org/10.1111/cyt.12270

Article  CAS  PubMed  Google Scholar 

L.A. Akslen, V.A. LiVolsi, Poorly differentiated thyroid carcinoma—it is important. Am. J. Surg. Pathol. 24, 310–313 (2000)

Article  CAS  PubMed  Google Scholar 

B. Xu, T. Ibrahimpasic, L. Wang, M.M. Sabra, J.C. Migliacci, R.M. Tuttle, I. Ganly, R. Ghossein, Clinicopathologic features of fatal non-anaplastic follicular cell-derived thyroid carcinomas. Thyroid 26(11), 1588–1597 (2016). https://doi.org/10.1089/thy.2016.0247

Article  CAS  PubMed  PubMed Central  Google Scholar 

V. Gnemmi, F. Renaud, C. Do Cao et al. Poorly differentiated thyroid carcinomas: application of the Turin proposal provides prognostic results similar to those from the assessment of high-grade features. Histopathology 64, 263–273 (2014)

Article  PubMed  Google Scholar 

M. Sobrinho-Simões, J. Albores-Saavedra, G. Tallini et al. Poorly differentiated thyroid carcinoma. in WHO Classification of Tumors, Pathology and Genetics—Tumors of Endocrine Organs, ed. by R.A. DeLellis, R.V. Lloyd, P.U. Heitz (IARC Press, Lyon, 2004) pp. 73–76

Z.W. Baloch, S.L. Asa, J.A. Barletta, R.A. Ghossein, C.C. Juhlin, C.K. Jung, V.A. LiVolsi, M.G. Papotti, M. Sobrinho-Simões, G. Tallini, O. Mete, Overview of the 2022 WHO classification of thyroid neoplasms. Endocr. Pathol. 33(1), 27–63 (2022). https://doi.org/10.1007/s12022-022-09707-3

Article  PubMed  Google Scholar 

A.M. Poma, E. Macerola, R.M.D. Ghossein, G. Tallini, F. Basolo, Prevalence of differentiated high-grade thyroid carcinoma among well-differentiated tumors: a systematic review and meta-analysis. Thyroid. (2023). https://doi.org/10.1089/thy.2023.0350

K.S. Wong, F. Dong, M. Telatar, J.H. Lorch, E.K. Alexander, E. Marqusee, N.L. Cho, M.A. Nehs, G.M. Doherty, M. Afkhami, J.A. Barletta, Papillary thyroid carcinoma with high-grade features versus poorly differentiated thyroid carcinoma: an analysis of clinicopathologic and molecular features and outcome. Thyroid 31(6), 933–940 (2021). https://doi.org/10.1089/thy.2020.0668

Article  CAS  PubMed  Google Scholar 

L.D.R. Thompson, High grade differentiated follicular cell-derived thyroid carcinoma versus poorly differentiated thyroid carcinoma: a clinicopathologic analysis of 41 cases. Endocr. Pathol. 34(2), 234–246 (2023). https://doi.org/10.1007/s12022-023-09770-4

Article  CAS  PubMed  Google Scholar 

M. Dettmer, A. Schmitt, H. Steinert, A. Haldemann, A. Meili, H. Moch, P. Komminoth, A. Perren, Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed? Am. J. Surg. Pathol. 35(12), 1866–1872 (2011). https://doi.org/10.1097/PAS.0b013e31822cf962

Article  PubMed  Google Scholar 

R.A. Bichoo, A. Mishra, N. Kumari, N. Krishnani, G. Chand, G. Agarwal, A. Agarwal, S.K. Mishra, Poorly differentiated thyroid carcinoma and poorly differentiated area in differentiated thyroid carcinoma: is there any difference? Langenbecks Arch. Surg. 404(1), 45–53 (2019). https://doi.org/10.1007/s00423-019-01753-6

Article  PubMed  Google Scholar 

B. Xu, R. Ghossein, Poorly differentiated thyroid carcinoma. Semin. Diagn. Pathol. 37(5), 243–247 (2020). https://doi.org/10.1053/j.semdp.2020.03.003

Article  PubMed  Google Scholar 

J.A. Fagin, S.A. Wells Jr, Biologic and clinical perspectives on thyroid cancer. N. Engl. J. Med. 375, 1054–1067 (2016)

Article  CAS  PubMed  PubMed Central  Google Scholar 

I. Landa, T. Ibrahimpasic, L. Boucai, R. Sinha, J.A. Knauf, R.H. Shah, S. Dogan, J.C. Ricarte-Filho, G.P. Krishnamoorthy, B. Xu, N. Schultz, M.F. Berger, C. Sander, B.S. Taylor, R. Ghossein, I. Ganly, J.A. Fagin, Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J. Clin. Invest. 126, 1052–1066 (2016)

Article  PubMed  PubMed Central  Google Scholar 

H. Duan, Y. Li, P. Hu, J. Gao, J. Ying, W. Xu, D. Zhao, Z. Wang, J. Ye, A. Lizaso, Y. He, H. Wu, Z. Liang, Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing. Histopathology 75(6), 890–899 (2019)

X. Yang, J. Li, X. Li, Z. Liang, W. Gao, J. Liang, S. Cheng, Y. Lin, TERT promoter mutation predicts radioiodine-refractory character in distant metastatic differentiated thyroid cancer. J. Nucl. Med. 58(2), 258–265 (2017). https://doi.org/10.2967/jnumed.116.180240

Article  CAS  PubMed  Google Scholar 

M.S. Brose, M.E. Cabanillas, E.E. Cohen, L.J. Wirth, T. Riehl, H. Yue, S.I. Sherman, E.J. Sherman, Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial. Lancet Oncol. 17(9), 1272–1282 (2016). https://doi.org/10.1016/S1470-2045(16)30166-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

A.L. Ho, R.K. Grewal, R. Leboeuf et al. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. N. Engl. J. Med. 368, 623–632 (2013)

Article  CAS  PubMed  PubMed Central  Google Scholar 

A.L. Ho, M. Dedecjus, L.J. Wirth, R.M. Tuttle, W.B. Inabnet 3rd, J. Tennvall, F. Vaisman, L. Bastholt, A.G. Gianoukakis, P. Rodien, R. Paschke, R. Elisei, D. Viola, K. So, D. Carroll, T. Hovey, B. Thakre, J.A. Fagin; ASTRA Investigator Group, Selumetinib plus adjuvant radioactive iodine in patients with high-risk differentiated thyroid cancer: a phase III, randomized, placebo-controlled trial (ASTRA). J. Clin. Oncol. 40(17), 1870–1878 (2022). https://doi.org/10.1200/JCO.21.00714

Article  CAS  PubMed  PubMed Central  Google Scholar 

S.Y. Hahn, J.H. Shin, Description and comparison of the sonographic characteristics of poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma. J. Ultrasound Med. 35(9), 1873–1879 (2016). https://doi.org/10.7863/ultra.15.09058

Article  PubMed  Google Scholar 

S. Basu, A. Kalshetty, Sub-segmentation specific paradigms for better individualized management of poorly differentiated thyroid carcinoma: can a systematic approach be evolved? Nucl. Med. Commun. 41(1), 1–4 (2020). https://doi.org/10.1097/MNM.0000000000001100

Article  PubMed